Autism Spectrum Disorders Are Prevalent Among Patients with Dystrophinopathies

Overview

Journal Neurol Sci

Specialty Neurology

Date 2018 Mar 30

PMID 29594829

Citations 18

Authors

Haruo Fujino

Toshio Saito

Tsuyoshi Matsumura

Saki Shibata

Yuko Iwata

Harutoshi Fujimura

Osamu Imura

Affiliations

Soon will be listed here.

Abstract

Recent studies have reported a higher prevalence of autism spectrum disorders among patients with dystrophinopathies. The aim of this study was to investigate the prevalence of autism spectrum disorder (ASD) among those with dystrophinopathies. The possible role of dystrophin isoforms in patients was also explored. Fifty-six patients recruited from Toneyama National Hospital were included in this study (mean age = 12.9 years, SD = 5.2 years). Autistic symptoms were evaluated using the Pervasive Developmental Disorders/Autism Spectrum Disorders Rating Scale (PARS), a clinician rating scale. Eleven patients (19.6%; 95% confidence interval 10.2-32.4) met the criteria for ASD based on their PARS scores. Patients were separated into two groups based on the cumulative loss of dystrophin isoforms predicted from the mutation location. The prevalence of ASD was examined between these groups. Infantile and current autistic symptoms did not differ between the groups, except on one subscale of the PARS. This study revealed that there was a high prevalence of ASD in patients with dystrophinopathies.

Citing Articles

Understanding rare variant contributions to autism: lessons from dystrophin-deficient model.

Costa C, Madanelo L, Wang J, da Silva Campos G, De Sanctis Girardi A, Scliar M NPJ Genom Med. 2025; 10(1):18.

PMID: 40050609 PMC: 11885547. DOI: 10.1038/s41525-025-00469-5.

Emerging Treatments and Therapies for Autism Spectrum Disorder: A Narrative Review.

Kaye A, Allen K, Smith Iii V, Tong V, Mire V, Nguyen H Cureus. 2024; 16(7):e63671.

PMID: 39092332 PMC: 11293483. DOI: 10.7759/cureus.63671.

Dmd mdx mice have defective oligodendrogenesis, delayed myelin compaction and persistent hypomyelination.

Arreguin A, Shao Z, Colognato H Dis Model Mech. 2024; 17(4).

PMID: 38721692 PMC: 11095635. DOI: 10.1242/dmm.050115.

Difficulties in social cognitive functioning among pediatric patients with muscular dystrophies.

Garcia I, Martinez O, Lopez-Paz J, Garcia M, Rodriguez A, Amayra I Front Psychol. 2024; 14:1296532.

PMID: 38239460 PMC: 10794305. DOI: 10.3389/fpsyg.2023.1296532.

Dystrophin genetic variants and autism.

Passos-Bueno M, Costa C, Zatz M Discov Ment Health. 2023; 2(1):4.

PMID: 37861890 PMC: 10501027. DOI: 10.1007/s44192-022-00008-z.

References

Ricotti V, Mandy W, Scoto M, Pane M, Deconinck N, Messina S . Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations. Dev Med Child Neurol. 2015; 58(1):77-84. DOI: 10.1111/dmcn.12922. View

Colombo P, Nobile M, Tesei A, Civati F, Gandossini S, Mani E . Assessing mental health in boys with Duchenne muscular dystrophy: Emotional, behavioural and neurodevelopmental profile in an Italian clinical sample. Eur J Paediatr Neurol. 2017; 21(4):639-647. DOI: 10.1016/j.ejpn.2017.02.007. View

Darke J, Bushby K, Le Couteur A, McConachie H . Survey of behaviour problems in children with neuromuscular diseases. Eur J Paediatr Neurol. 2006; 10(3):129-34. DOI: 10.1016/j.ejpn.2006.04.004. View

Hinton V, Cyrulnik S, Fee R, Batchelder A, Kiefel J, Goldstein E . Association of autistic spectrum disorders with dystrophinopathies. Pediatr Neurol. 2009; 41(5):339-46. DOI: 10.1016/j.pediatrneurol.2009.05.011. View

Taylor P, Betts G, Maroulis S, Gilissen C, Pedersen R, Mowat D . Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLoS One. 2010; 5(1):e8803. PMC: 2808359. DOI: 10.1371/journal.pone.0008803. View

Kumagai T, Miura K, Ohki T, Matsumoto A, Miyazaki S, Nakamura M . [Central nervous system involvements in Duchenne/Becker muscular dystrophy]. No To Hattatsu. 2001; 33(6):480-6. View

Pane M, Lombardo M, Alfieri P, DAmico A, Bianco F, Vasco G . Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. J Pediatr. 2012; 161(4):705-9.e1. DOI: 10.1016/j.jpeds.2012.03.020. View

Latimer R, Street N, Conway K, James K, Cunniff C, Oleszek J . Secondary Conditions Among Males With Duchenne or Becker Muscular Dystrophy. J Child Neurol. 2017; 32(7):663-670. PMC: 5502756. DOI: 10.1177/0883073817701368. View

Wu J, Kuban K, Allred E, Shapiro F, Darras B . Association of Duchenne muscular dystrophy with autism spectrum disorder. J Child Neurol. 2006; 20(10):790-5. DOI: 10.1177/08830738050200100201. View

10.

Banihani R, Smile S, Yoon G, Dupuis A, Mosleh M, Snider A . Cognitive and Neurobehavioral Profile in Boys With Duchenne Muscular Dystrophy. J Child Neurol. 2015; 30(11):1472-82. DOI: 10.1177/0883073815570154. View

11.

Hendriksen J, Vles J . Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive--compulsive disorder. J Child Neurol. 2008; 23(5):477-81. DOI: 10.1177/0883073807309775. View